About Oncology Institute Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://theoncologyinstitute.com/
Frequently Asked Questions
What is the 52-week range for STLN?
The 52-week high is $7.13 and the 52-week low is $4.85.
What is the P/E ratio for STLN?
The P/E ratio data is currently unavailable.
What is the dividend yield for STLN?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -482.58%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -6.18%.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for STLN over the last few months:
Latest STLN News
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Physician leaders share clinical insights on value-based therapy delivery, clinical trial access and integrated behavioral health in community oncology at major industry forumsCERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today highlighted its leadership team’s active season of industry engagement, recapping recent conference participation and p
Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating
Starling Oncology's revenue model leverages scalable delegation contracts, driving higher PMPM fees and pharmacy growth. Learn why STLN stock is a buy.